The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells

被引:192
作者
Bruschi, Francesca Virginia [1 ]
Claudel, Thierry [1 ]
Tardelli, Matteo [2 ,3 ]
Caligiuri, Alessandra [4 ]
Stulnig, Thomas M. [2 ,3 ]
Marra, Fabio [2 ,3 ]
Trauner, Michael [1 ]
机构
[1] Med Univ Vienna, Div Gastroenterol & Hepatol, Hans Popper Lab Mol Hepatol, Vienna, Austria
[2] Med Univ Vienna, Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria
[3] Med Univ Vienna, Clin Div Endocrinol & Metab, Internal Med 3, Vienna, Austria
[4] Univ Florence, Dept Expt & Clin Med, Florence, Italy
关键词
FATTY LIVER-DISEASE; ACTIVATED RECEPTOR-GAMMA; 9-CIS RETINOIC ACID; N-TERMINAL KINASE; KAPPA-B; FIBROSIS; STEATOSIS; STEATOHEPATITIS; SUSCEPTIBILITY; METAANALYSIS;
D O I
10.1002/hep.29041
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The genetic polymorphism I148M of patatin-like phospholipase domain-containing 3 (PNPLA3) is robustly associated with hepatic steatosis and its progression to steatohepatitis, fibrosis, and cancer. Hepatic stellate cells (HSCs) are key players in the development of liver fibrosis, but the role of PNPLA3 and its variant I148M in this process is poorly understood. Here we analyzed the expression of PNPLA3 during human HSC activation and thereby explored how a PNPLA3 variant impacts hepatic fibrogenesis. We show that expression of PNPLA3 gene and protein increases during the early phases of activation and remains elevated in fully activated HSCs (P < 0.01). Knockdown of PNPLA3 significantly decreases the profibrogenic protein alpha-smooth muscle actin (P < 0.05). Primary human I148M HSCs displayed significantly higher expression and release of proinflammatory cytokines, such as chemokine (C-C motif) ligand 5 (P < 0.01) and granulocyte-macrophage colony-stimulating factor (P < 0.001), thus contributing to migration of immune cells (P < 0.05). Primary I148M HSCs showed reduced retinol (P < 0.001) but higher lipid droplet content (P < 0.001). In line with this, LX-2 cells stably overexpressing I148M showed augmented proliferation and migration, lower retinol, and abolished retinoid X receptor/retinoid A receptor transcriptional activities but more lipid droplets. Knockdown of I148M PNPLA3 (P < 0.001) also reduces chemokine (C-C motif) ligand 5 and collagen1a1 expression (P < 0.05). Notably, I148M cells display reduced peroxisome proliferator-activated receptor gamma transcriptional activity, and this effect was attributed to increased c-Jun N-terminal kinase, thereby inhibiting peroxisome proliferator-activated receptor gamma through serine 84 phosphorylation and promoting activator protein 1 transcription. Conversely, the c-Jun N-terminal kinase inhibitor SP600125 and the peroxisome proliferator-activated receptor gamma agonist rosiglitazone decreased activator protein 1 promoter activity. Conclusions: These data indicate that PNPLA3 is required for HSC activation and that its genetic variant I148M potentiates the profibrogenic features of HSCs, providing a molecular mechanism for the higher risk of progression and severity of liver diseases conferred to patients carrying the I148M variant.
引用
收藏
页码:1875 / 1890
页数:16
相关论文
共 35 条
[1]   Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome [J].
Basantani, Mahesh K. ;
Sitnick, Mitch T. ;
Cai, Lingzhi ;
Brenner, Daniel S. ;
Gardner, Noah P. ;
Li, John Zhong ;
Schoiswohl, Gabriele ;
Yang, Kui ;
Kumari, Manju ;
Gross, Richard W. ;
Zechner, Rudolf ;
Kershaw, Erin E. .
JOURNAL OF LIPID RESEARCH, 2011, 52 (02) :318-329
[2]   Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver [J].
Friedman, Scott L. .
PHYSIOLOGICAL REVIEWS, 2008, 88 (01) :125-172
[3]   Hepatic fibrosis-Overview [J].
Friedman, Scott L. .
TOXICOLOGY, 2008, 254 (03) :120-129
[4]   Kinase signaling cascades that modulate peroxisome proliferator-activated receptors [J].
Gelman, L ;
Michalik, L ;
Desvergne, A ;
Wahli, W .
CURRENT OPINION IN CELL BIOLOGY, 2005, 17 (02) :216-222
[5]   Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells [J].
Hazra, S ;
Xiong, SG ;
Wang, JH ;
Rippe, RA ;
Chatterjee, VKK ;
Tsukamoto, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (12) :11392-11401
[6]   Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids [J].
Hellemams, K ;
Verbuyst, P ;
Quartier, E ;
Schuit, F ;
Rombouts, K ;
Chandraratna, RAS ;
Schuppan, D ;
Geerts, A .
HEPATOLOGY, 2004, 39 (01) :97-108
[7]   All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially [J].
Hellemans, K ;
Grinko, I ;
Rombouts, K ;
Schuppan, D ;
Geerts, A .
GUT, 1999, 45 (01) :134-142
[8]   A feed-forward loop amplifies nutritional regulation of PNPLA3 [J].
Huang, Yongcheng ;
He, Shaoqing ;
Li, John Zhong ;
Seo, Young-Kyo ;
Osborne, Timothy F. ;
Cohen, Jonathan C. ;
Hobbs, Helen H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (17) :7892-7897
[9]   Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities [J].
Jenkins, CM ;
Mancuso, DJ ;
Yan, W ;
Sims, HF ;
Gibson, B ;
Gross, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48968-48975
[10]   Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition [J].
Kluwe, Johannes ;
Pradere, Jean-Philippe ;
Gwak, Geum-Youn ;
Mencin, Ali ;
De Minicis, Samuele ;
Oesterreicher, Christoph H. ;
Colmenero, Jordi ;
Bataller, Ramon ;
Schwabe, Robert F. .
GASTROENTEROLOGY, 2010, 138 (01) :347-359